Jb Capital LLC Abb Vie Inc. Transaction History

Jb Capital LLC

$1.71 Billion
Q3 2024

A detailed history of Jb Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Jb Capital LLC holds 4,328 shares of ABBV stock, worth $759,910. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,328

Previous 4,888 11.46%

Holding current value

$759,910

Previous $838,000 1.91%

% of portfolio

0.05%

Previous 0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$163.84 - $199.33 $91,750 - $111,624	-560 Reduced 11.46%	4,328 $854,000
Q2 2024 Jul 24, 2024	BUY	$154.79 - $180.76 $5,572 - $6,507	36 Added 0.74%	4,888 $838,000
Q1 2024 Apr 30, 2024	BUY	$159.82 - $182.1 $19,018 - $21,669	119 Added 2.51%	4,852 $883,000
Q4 2023 Jan 22, 2024	BUY	$137.6 - $154.97 $37,840 - $42,616	275 Added 6.17%	4,733 $733,000
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $20,840 - $24,125	-156 Reduced 3.38%	4,458 $664,000
Q2 2023 Jul 25, 2023	SELL	$132.51 - $164.9 $16,961 - $21,107	-128 Reduced 2.7%	4,614 $621,000
Q1 2023 Apr 25, 2023	SELL	$144.61 - $166.54 $24,005 - $27,645	-166 Reduced 3.38%	4,742 $755,000
Q4 2022 Jan 23, 2023	SELL	$138.31 - $165.87 $22,682 - $27,202	-164 Reduced 3.23%	4,908 $0
Q3 2022 Oct 14, 2022	SELL	$134.21 - $153.93 $3.82 Million - $4.38 Million	-28,458 Reduced 84.87%	5,072 $681,000
Q2 2022 Jul 28, 2022	SELL	$137.62 - $174.96 $2.42 Million - $3.08 Million	-17,601 Reduced 34.42%	33,530 $5.14 Million
Q1 2022 Apr 19, 2022	SELL	$131.98 - $163.75 $248,518 - $308,341	-1,883 Reduced 3.55%	51,131 $8.29 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $310,365 - $392,701	2,889 Added 5.76%	53,014 $7.18 Million
Q3 2021 Dec 08, 2021	BUY	$106.4 - $120.78 $5.33 Million - $6.05 Million	50,125 New	50,125 $5.41 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jb Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jb Capital LLC with notifications on news.

Account